Welcome to the Empowered Patient Podcast with Karen Jagoda. This show is a window into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the changing dynamics in the medical and healthcare environment. One focus is on how providers, pharmaceutical companies, and payers are empowering patients. In addition, conversations are often about how providers, care facilities, pharmaceutical companies, and payers are being empowered by technology to improve patient outcomes and reduce friction across the healthcare landscape.
Popular Topics
- Virtual and digital health
- Use of AI, ML, and LLM in healthcare and drug discovery, development, trials
- Value-based healthcare
- Precision and stratified medicine
- Integration of digital technology into existing workflow and procedures
- Next-generation immuno, cell, and gene therapies
- Vaccines
- Biomarkers, sequencing, and imaging
- Rare diseases
- MedTech and medical devices
- Clinical trials
- Addressing Social Determinants of Health
- Treating chronic conditions like obesity and pain
- Clinician and staff burnout
The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.
Check out our new EmpoweredPatient.Solutions site where you can quickly search all of the Empowered Patient Podcast interviews by any word or phrase to identify useful resources, potential partners, and insights about the life sciences landscape.
Sep 11, 2018
Dr. Anish Bhatnagar, CEO of Soleno Therapeutics, discusses Prader-Willi syndrome, a rare genetic disease that among other difficult symptoms, most markedly renders patients perpetually starving because of a dysfunctional neural pathway in the brain. This state, otherwise known as hyperphagia, can bring patients to the brink of severe sickness from overeating despite bring full, or from eating garbage, spoiled food, or sometimes even inedible objects. Anish talks about the hardships that this disease inflicts on its patients and its patients’ loved ones raising them, and about DCCR, the experimental treatment his company is developing to address this significantly unmet need for patients struggling with PWS.
#Prader-Willi #PWS #SolenoTx #SLNO #RareDisease #DCCR